Clinical trial
Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in…
NCT00319501 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00319501 |
|---|---|
| Title | Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. |
| Official title | A Phase 3, Randomized, Double-blind, Parallel, Placebo-controlled, Multicenter Study, With Optional Open-label Continuation, Of The Efficacy And Safety Of Vanquix(tm) Auto-injector (Diazepam Injection) For The Management Of Selected, Refractory, Patients With Epilepsy Who Require Intermittent… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Seizures, Epilepsies, Partial, Epilepsy, Complex Partial, Generalized |
| Intervention type | Drug |
| Interventions | Placebo, Vanquix Auto-Injector (Diazepam Injection) |
| Enrollment | 234 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2014 |
| Completion | Jul 1, 2014 |
| First posted | Apr 27, 2006 |
| Last update posted | Sep 23, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: